The mode of administration of total parenteral nutrition and nature of lipid content influence the generation of peroxides and aldehydes.
OBJECTIVE
The absence of light protection of neonatal total parenteral nutrition (PN) contributes to the generation of 4-hydroxynonenal and peroxides. 4-Hydroxynonenal is suspected to be involved in PN-related liver complications.


OBJECTIVE
To find a practical modality to reduce 4-hydroxynonenal in PN and assess in vivo the impact of PN containing low 4-hydroxynonenal concentration.


METHODS
Six modalities of delivering PN were compared for the in vitro generation of peroxides and 4-hydroxynonenal: 1) MV-AA-L: light-protected (-L) solution containing multivitamin (MV) mixed with amino acids + dextrose (AA); 2) MV-AA+L: MV-AA without photo-protection (+L); 3) MV-LIP+L: MV mixed with lipid emulsion (LIP). LIP was a) Intralipid20%(®) or b) Omegaven(®). Hepatic markers of oxidative stress (glutathione, F(2α)-isoprostanes, GS-HNE) and inflammation (mRNA of TNF-α and IL-1) were measured in newborn guinea pigs infused during 4-days with MV-AA+L compounded with Intralipid20%(®) or Omegaven(®).


RESULTS
Hydroperoxides and 4-hydroxynonenal were the lowest in MV-AA-L and the highest in MV-LIP+L. MV-AA+L with Omegaven(®) was associated with the lowest levels of markers of oxidative stress and inflammation.


CONCLUSIONS
Compared to Intralipid20%(®), Omegaven(®) reduces oxidative stress associated with PN and prevents liver inflammation. These findings offer an alternative strategy to light protection of PN, which in the clinical setting is a cumbersome modality.
Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, Montréal, QC, Canada.
Khalil
K
Miloudi
Blandine
B
Comte
Thérèse
T
Rouleau
Alain
A
Montoudis
Emile
E
Levy
Jean-Claude
JC
Lavoie
D000447:Aldehydes / Q000378:metabolism*; D000596:Amino Acids / Q000008:administration & dosage; D000818:Animals; D004655:Emulsions / Q000008:administration & dosage; D005395:Fish Oils / Q000008:administration & dosage; D005947:Glucose / Q000008:administration & dosage; D005978:Glutathione / Q000378:metabolism; D006168:Guinea Pigs; D006861:Hydrogen Peroxide / Q000378:metabolism*; D007249:Inflammation / Q000188:drug therapy / Q000517:prevention & control; D007375:Interleukin-1 / Q000378:metabolism; D008099:Liver / Q000378:metabolism / Q000473:pathology; D018384:Oxidative Stress / Q000187:drug effects; D057947:Parenteral Nutrition Solutions / Q000008:administration & dosage*; D010289:Parenteral Nutrition, Total / Q000379:methods*; D010743:Phospholipids / Q000008:administration & dosage; D013024:Soybean Oil / Q000008:administration & dosage; D014280:Triglycerides; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D014815:Vitamins / Q000008:administration & dosage
D000447:Aldehydes; D000596:Amino Acids; D004655:Emulsions; D005395:Fish Oils; D007375:Interleukin-1; D057947:Parenteral Nutrition Solutions; D010743:Phospholipids; D014280:Triglycerides; D014409:Tumor Necrosis Factor-alpha; D014815:Vitamins; C568345:fish oil triglycerides; C545823:soybean oil, phospholipid emulsion; D013024:Soybean Oil; D006861:Hydrogen Peroxide; D005978:Glutathione; D005947:Glucose; C027576:4-hydroxy-2-nonenal